{"SPADE_UN_16978": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_16978", "Peptide Name": "Longicalycinin A cyclic analogue 2", "Source": "Synthetic", "Family": "", "Gene": "Not found", "Sequence": "LYPFA", "Sequence Length": 5, "UniProt Entry": ["http://www.uniprot.org/uniprot/Notavailable"], "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Anticancer"], "Target Organism": "Tumor cells:HepG2 (IC50=8.76 ± 0.0035 μg/mL); HT-29 (IC50=12.33 ± 0 μg/mL)", "Hemolytic Activity": "Not available", "Cytotoxicity": "Not available", "Binding Target": "Not available", "Linear/Cyclic": "Linear", "N-terminal Modification": "Free", "C-terminal Modification": "Free", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C32H43N5O7", "Mass": 609.71, "PI": 5.52, "Net Charge": 0, "Hydrophobicity": 1.1, "Half Life": "Mammalian:5.5 hourYeast:3 minE.coli:2 min", "Literature": [{"Title": "Structure-activity relationship studies of Longicalcynin A analogues, as anticancer cyclopeptides", "Pubmed ID": "31747558", "Reference": "Chem Biol Interact. 2020 Jan 5;315108902.", "Author": "Gholibeikian M, Bamoniri A, HoushdarTehrani MH, Fatemeh Mirjalili BB, Bijanzadeh HR.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=31747558"}], "Frequent Amino Acids": "AFL", "Absent Amino Acids": "CDEGHIKMNOQRSTUVW", "Basic Residues": 0, "Acidic Residues": 0, "Hydrophobic Residues": 5, "Polar Residues": 2, "Positive Residues": 0, "Negative Residues": 0, "Similar Sequences": [{"SPADE_ID": "SPADE_N_09913", "Similarity": 1.0, "Sequence": "VKLKYPVKLYP"}, {"SPADE_ID": "SPADE_N_09914", "Similarity": 1.0, "Sequence": "VKLYPKVKLYP"}, {"SPADE_ID": "SPADE_N_09915", "Similarity": 1.0, "Sequence": "VKKYPKVKLYP"}]}}}